Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

Design Therapeutics (DSGN) FCF Margin (2020)

Design Therapeutics' FCF Margin history spans 1 years, with the latest figure at 8660.61% for Q4 2020.

  • For Q4 2020, FCF Margin changed N/A year-over-year to 8660.61%; the TTM value through Sep 2021 reached 70060.61%, changed N/A, while the annual FY2025 figure was 563.83%, 22429.0% down from the prior year.
  • FCF Margin for Q4 2020 was 8660.61% at Design Therapeutics, up from 9295.0% in the prior quarter.
  • Across five years, FCF Margin topped out at 1872.54% in Q1 2020 and bottomed at 9295.0% in Q3 2020.